Dangerous drug batches recalled by Pharmacy Board
Three brands of Paracetamol 1000mg/100ml injections were listed in the recall, all of which showed colour changes that raised concern over their quality.
The Pharmacy and Poisons Board has recalled several batches of medicines found to be substandard or falsified, warning the public of possible health risks linked to their use.
In a statement released on Thursday, PPB Chief Executive Officer Fred Siyoi said the recalled products include Paracetamol injections showing abnormal colour, falsified Augmentin tablets, and a case where Levofloxacin was found in a pack meant for Esomeprazole.
Three brands of Paracetamol 1000mg/100ml injections were listed in the recall, all of which showed colour changes that raised concern over their quality.
The affected batches include Lumidol Injection (Batch Numbers CM4594007, CM4594008, CM4594009), Blink Injection (Batch Numbers C84594005, CS4594004), and Paragen Injection (Batch Number K4290027).
These were all manufactured by KamlaAmrut Pharmaceutical LLP of India.
The Board also flagged a product mix-up involving S-Prazo (Esomeprazole 40mg), Batch No. SPZ404.
Inside a pack of this drug, a strip of Levofloxacin 500mg tablets was discovered, posing a serious risk to users.
Further, PPB revealed the presence of falsified Augmentin tablets in the market.
The affected products include AUGMENTIN 1G – Batch SGS2 and AUGMENTIN 625mg – Batch Numbers 8X3K and EU7C.
"The Pharmacy and Poisons Board urges all pharmaceutical outlets, healthcare providers, and members of the public to immediately stop distributing, selling, issuing, or using the affected product batches," Siyoi said.
"Anyone in possession of the flagged drugs is advised to return them to the nearest healthcare facility or supplier."
Kenyans are being urged to report any suspected substandard or falsified medicines, or cases of adverse reactions, either through nearby health facilities or directly to the Board using its official reporting channels.